# Cancer Treatment Reviews

**Type:** Journals  
**Canonical URL:** https://scholariq.org/journals/cancer-treatment-reviews/

## Facts

| Field | Value |
| --- | --- |
| Open Access | false |
| ISSN-L | 0305-7372 |
| ISSNs | 0305-7372,1532-1967 |
| OpenAlex ID | https://openalex.org/S49831067 |
| Publisher | Elsevier BV |

## Journal papers

Showing 12 of 21.

- [Bevacizumab (Avastin®) in cancer treatment: A review of 15 years of clinical experience and future outlook](https://scholariq.org/papers/bevacizumab-avastin-in-cancer-treatment-a-review-of-15-years-of-clinical/)
- [Cellular pH regulators: potentially promising molecular targets for cancer chemotherapy](https://scholariq.org/papers/cellular-ph-regulators-potentially-promising-molecular-targets-for-cancer/)
- [Effects and moderators of exercise on quality of life and physical function in patients with cancer: An individual patient data meta-analysis of 34 RCTs](https://scholariq.org/papers/effects-and-moderators-of-exercise-on-quality-of-life-and-physical-function-in/)
- [Management of locally recurrent nasopharyngeal carcinoma](https://scholariq.org/papers/management-of-locally-recurrent-nasopharyngeal-carcinoma/)
- [Depression in cancer: The many biobehavioral pathways driving tumor progression](https://scholariq.org/papers/depression-in-cancer-the-many-biobehavioral-pathways-driving-tumor-progression/)
- [RET fusions in solid tumors](https://scholariq.org/papers/ret-fusions-in-solid-tumors/)
- [Management of adverse events associated with tyrosine kinase inhibitors: Improving outcomes for patients with hepatocellular carcinoma](https://scholariq.org/papers/management-of-adverse-events-associated-with-tyrosine-kinase-inhibitors/)
- [Prognostic role of pretreatment plasma fibrinogen in patients with solid tumors: A systematic review and meta-analysis](https://scholariq.org/papers/prognostic-role-of-pretreatment-plasma-fibrinogen-in-patients-with-solid-tumors/)
- [BRAF in non-small cell lung cancer (NSCLC): Pickaxing another brick in the wall](https://scholariq.org/papers/braf-in-non-small-cell-lung-cancer-nsclc-pickaxing-another-brick-in-the-wall/)
- [Treatment of advanced HER2-positive breast cancer: 2018 and beyond](https://scholariq.org/papers/treatment-of-advanced-her2-positive-breast-cancer-2018-and-beyond/)
- [Balancing the benefits and harms of thyroid cancer surveillance in survivors of Childhood, adolescent and young adult cancer: Recommendations from the international Late Effects of Childhood Cancer Guideline Harmonization Group in collaboration with the PanCareSurFup Consortium](https://scholariq.org/papers/balancing-the-benefits-and-harms-of-thyroid-cancer-surveillance-in-survivors-of/)
- [Proton beams in cancer treatments: Clinical outcomes and dosimetric comparisons with photon therapy](https://scholariq.org/papers/proton-beams-in-cancer-treatments-clinical-outcomes-and-dosimetric-comparisons/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.